Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewTAK 779 is a potent and selective CCR5 and CCR2 chemokine receptor antagonist (IC50 values = 1 nM and 27 nM, respectively). TAK 779 blocks the binding of macrophage inflammatory protein 1α and 1β to CHO cells (IC50 = 1 nM) and inhibits replication of R5 HIV-1 at 1.6-3.7 nM. In animal models, TAK 779 protects against ischemic brain injury and prevents development of asthma features.
M. Wt | 531.13 |
Formula | C33H39N2O2.Cl |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 229005-80-5 |
PubChem ID | 183789 |
InChI Key | VDALIBWXVQVFGZ-UHFFFAOYSA-N |
Smiles | CC1=CC=C(C2=CC(C=C(C(NC3=CC=C(C[N+](C)(C)C4CCOCC4)C=C3)=O)CCC5)=C5C=C2)C=C1.[Cl-] |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
water | 5.31 | 10 | |
DMSO | 2.66 | 5 |
The following data is based on the product molecular weight 531.13. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.83 mL | 94.14 mL | 188.28 mL |
0.5 mM | 3.77 mL | 18.83 mL | 37.66 mL |
1 mM | 1.88 mL | 9.41 mL | 18.83 mL |
5 mM | 0.38 mL | 1.88 mL | 3.77 mL |
References are publications that support the biological activity of the product.
Baba et al (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc.Natl.Acad.Sci.U.S.A. 96 5698 PMID: 10318947
Suzaki et al (2008) A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation. Eur.Respir.J. 31 783 PMID: 18094012
Takami et al (2002) TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice. J.Cereb.Blood Flow Metab. 22 780 PMID: 12142563
If you know of a relevant reference for TAK 779, please let us know.
Keywords: TAK 779, TAK 779 supplier, TAK779, potent, selective, chemokines, receptors, antagonists, CCR5, CCR2, macrophage, viral, replication, ischemia, asthma, Chemokine, CC, Receptors, HIV, 4340, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for TAK 779. Do you know of a great paper that uses TAK 779 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review TAK 779 and earn rewards!
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.